Charles Bangham
#102,472
Most Influential Person Now
Chair of Immunology at Imperial College London
Charles Bangham's AcademicInfluence.com Rankings
Charles Banghambiology Degrees
Biology
#6323
World Rank
#9009
Historical Rank
Immunology
#437
World Rank
#454
Historical Rank
Download Badge
Biology
Why Is Charles Bangham Influential?
(Suggest an Edit or Addition)According to Wikipedia, Charles Bangham holds the Chair in Immunology at Imperial College London. Education Bangham was educated at the University of Cambridge and the University of Oxford where he was awarded a Bachelor of Medicine, Bachelor of Surgery . He completed his PhD on immune responses to respiratory syncytial virus while working at the National Institute for Medical Research in 1987.
Charles Bangham's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Population Dynamics of Immune Responses to Persistent Viruses (1996) (1199)
- Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition (1991) (1068)
- Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. (1997) (790)
- Spread of HTLV-I Between Lymphocytes by Virus-Induced Polarization of the Cytoskeleton (2003) (714)
- Analysis Of Htlv-I Proviral Load In 202 Ham/Tsp Patients And 243 Asymptomatic Htlv-I Carriers: High Proviral Load Strongly Predisposes To Ham/Tsp (1998) (397)
- Antigenic oscillations and shifting immunodominance in HIV-1 infections (1995) (357)
- Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial (2014) (334)
- Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. (1999) (295)
- The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. (2011) (267)
- The immune control and cell-to-cell spread of human T-lymphotropic virus type 1. (2003) (246)
- Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. (1992) (211)
- The Influence of HLA Class I Alleles and Heterozygosity on the Outcome of Human T Cell Lymphotropic Virus Type I Infection1 (2000) (211)
- Selection Forces and Constraints on Retroviral Sequence Variation (2001) (204)
- Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants. (1986) (204)
- Cellular immune response to HTLV-1 (2005) (189)
- Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates (1990) (176)
- Do infectious diseases drive MHC diversity? (2000) (175)
- Estimating T-cell repertoire diversity: limitations of classical estimators and a new approach (2015) (169)
- Diagnosis of viral infections of the central nervous system: clinical interpretation of PCR results (1997) (168)
- Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy (2007) (165)
- The immune response to HTLV-I. (2000) (165)
- Aseptic meningitis and encephalitis: the role of PCR in the diagnostic laboratory (1997) (160)
- Human T-lymphotropic Virus, Type 1, Tax Protein Triggers Microtubule Reorientation in the Virological Synapse* (2005) (140)
- CELL-MEDIATED CYTOTOXIC RESPONSE TO RESPIRATORY SYNCYTIAL VIRUS IN INFANTS WITH BRONCHIOLITIS (1987) (139)
- CTL quality and the control of human retroviral infections (2009) (137)
- HLA Class I Binding of HBZ Determines Outcome in HTLV-1 Infection (2010) (130)
- HTLV-1 infections (2000) (126)
- The immunogenicity of intracerebral virus infection depends on anatomical site (1997) (124)
- Engagement of specific T-cell surface molecules regulates cytoskeletal polarization in HTLV-1-infected lymphocytes. (2005) (120)
- Lymphocyte kinetics: the interpretation of labelling data. (2002) (120)
- High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1–specific CTL response (2007) (119)
- In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection (2007) (118)
- Long-Term Persistence of Activated Cytotoxic T Lymphocytes after Viral Infection of the Central Nervous System (1998) (115)
- Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously (1994) (115)
- Cytotoxic T-cell response to respiratory syncytial virus in mice (1985) (112)
- Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial (2006) (109)
- HTLV-1-associated myelopathy/tropical spastic paraparesis (2015) (107)
- Estimating abundances of retroviral insertion sites from DNA fragment length data (2012) (107)
- Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax (1995) (106)
- Cycles, chaos, and evolution in virus cultures: a model of defective interfering particles. (1994) (106)
- HTLV-1 Integration into Transcriptionally Active Genomic Regions Is Associated with Proviral Expression and with HAM/TSP (2008) (103)
- The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma. (2014) (102)
- Reducing the global burden of HTLV‐1 infection: An agenda for research and action (2017) (102)
- Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen. (2011) (101)
- Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAs. (2011) (100)
- Human T-Lymphotropic Virus-1 Visualized at the Virological Synapse by Electron Tomography (2008) (98)
- Local Suppression of T Cell Responses by Arginase-Induced L-Arginine Depletion in Nonhealing Leishmaniasis (2009) (98)
- Genome-wide Determinants of Proviral Targeting, Clonal Abundance and Expression in Natural HTLV-1 Infection (2013) (98)
- HTLV-1-Tax and ICAM-1 act on T-cell signal pathways to polarize the microtubule-organizing center at the virological synapse. (2009) (95)
- The dynamics of HTLV-I and the CTL response. (1999) (95)
- HTLV-1 inserts an ectopic CTCF-binding site into the human genome (2015) (95)
- The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis (1994) (94)
- High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. (2002) (93)
- Systems Biology Approaches Reveal a Specific Interferon-Inducible Signature in HTLV-1 Associated Myelopathy (2012) (91)
- A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. (2005) (88)
- Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis. (2002) (88)
- High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis. (1996) (85)
- Human T Cell Leukemia Virus Type 1: Persistence and Pathogenesis. (2018) (85)
- HTLV-1-infected T cells contain a single integrated provirus in natural infection. (2012) (85)
- HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection (2014) (83)
- The Role of CTLs in Persistent Viral Infection: Cytolytic Gene Expression in CD8+ Lymphocytes Distinguishes between Individuals with a High or Low Proviral Load of Human T Cell Lymphotropic Virus Type 1 (2004) (82)
- Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy. (2004) (81)
- Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells. (1994) (79)
- Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors. (2010) (79)
- Single-cell heterogeneity and cell-cycle-related viral gene bursts in the human leukaemia virus HTLV-1 (2017) (79)
- How does HTLV-1 cause adult T-cell leukaemia/lymphoma (ATL)? (2015) (76)
- HTLV-1-associated myelopathy/tropical spastic paraparesis (2015) (74)
- Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus. (1986) (73)
- Cell dynamics and immune response to BLV infection: a unifying model. (2007) (72)
- KIR2DL2 Enhances Protective and Detrimental HLA Class I-Mediated Immunity in Chronic Viral Infection (2011) (69)
- Quantification of HTLV-1 Clonality and TCR Diversity (2014) (69)
- How does HTLV-I persist despite a strong cell-mediated immune response? (2008) (65)
- Human T Cell Lymphotropic Virus Type I (HTLV-I)-Specific CD4+ T Cells: Immunodominance Hierarchy and Preferential Infection with HTLV-I1 (2004) (65)
- In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome. (2011) (64)
- Quantifying HTLV‐I dynamics (2007) (63)
- Human T-Lymphotropic Virus Type 1-Induced CC Chemokine Ligand 22 Maintains a High Frequency of Functional FoxP3+ Regulatory T Cells (2010) (63)
- Quantification of the virus-host interaction in human T lymphotropic virus I infection (2005) (62)
- The Avidity and Lytic Efficiency of the CTL Response to HTLV-11 (2009) (62)
- Cytotoxic T–cell abundance and virus load in human immunodeficiency virus type 1 and human T–cell leukaemia virus type 1 (2001) (59)
- FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV‐1–associated adult T‐cell leukemia (2009) (58)
- Defective interfering particles: effects in modulating virus growth and persistence. (1990) (57)
- High Circulating Frequencies of Tumor Necrosis Factor Alpha- and Interleukin-2-Secreting Human T-Lymphotropic Virus Type 1 (HTLV-1)-Specific CD4+ T Cells in Patients with HTLV-1-Associated Neurological Disease (2003) (56)
- Human T-cell leukemia virus type 1 infects multiple lineage hematopoietic cells in vivo (2017) (56)
- Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. (2004) (56)
- HTLV-1 Propels Thymic Human T Cell Development in “Human Immune System” Rag2-/- gamma c-/- Mice (2011) (55)
- The HTLV-1 Virological Synapse (2010) (55)
- Human T-cell leukaemia virus type 1: parasitism and pathogenesis (2017) (53)
- Safety of long-term treatment of HAM/TSP patients with valproic acid. (2011) (52)
- The immune control of HTLV-1 infection: selection forces and dynamics. (2009) (51)
- Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo (2013) (51)
- Human T-Lymphotropic Virus Type 1 (HTLV-1): Persistence and Immune Control (2003) (50)
- Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I. (1999) (50)
- Activation of interleukin-13 expression in T cells from HTLV-1-infected individuals and in chronically infected cell lines. (2003) (49)
- Increased level of arginase activity correlates with disease severity in HIV-seropositive patients. (2010) (49)
- Glucose Metabolism and Oxygen Availability Govern Reactivation of the Latent Human Retrovirus HTLV-1 (2017) (48)
- Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients (2016) (47)
- Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis. (2002) (46)
- The cytotoxic T-lymphocyte response to HTLV-I: the main determinant of disease? (1996) (46)
- The human leukemia virus HTLV-1 alters the structure and transcription of host chromatin in cis (2018) (46)
- Intradermal DNA immunization of mice against influenza A virus using the novel PowderJect system. (1998) (45)
- Evolutionary Dynamics of HTLV-I (1999) (45)
- CADM1/TSLC1 Identifies HTLV-1-Infected Cells and Determines Their Susceptibility to CTL-Mediated Lysis (2016) (45)
- The dynamics of T-cell fratricide: application of a robust approach to mathematical modelling in immunology. (2003) (44)
- Is human T-cell lymphotropic virus type I really silent? (2000) (44)
- HTLV-1: Regulating the Balance Between Proviral Latency and Reactivation (2018) (42)
- Histone deacetylase inhibitors increase virus gene expression but decrease CD8+ cell antiviral function in HTLV-1 infection. (2006) (40)
- Virus dissemination through the brain parenchyma without immunologic control. (1997) (40)
- PCR analysis of DNA from multiple sclerosis patients for the presence of HTLV-I (1989) (39)
- Evolution of retrovirus-infected premalignant T-cell clones prior to Adult T-cell leukemia/lymphoma diagnosis. (2020) (38)
- Review. An introduction to lymphocyte and viral dynamics: the power and limitations of mathematical analysis (2003) (37)
- Murine cytotoxic T cells specific to respiratory syncytial virus recognize different antigenic subtypes of the virus. (1986) (37)
- Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers. (2003) (37)
- Human T-Lymphotropic Virus type 1c subtype proviral loads, chronic lung disease and survival in a prospective cohort of Indigenous Australians (2018) (37)
- The protean immune cell synapse: a supramolecular structure with many functions. (2003) (35)
- Immunopathogenesis of Human T-Cell Leukemia Virus Type-1-Associated Myelopathy/Tropical Spastic Paraparesis: Recent Perspectives (2012) (35)
- Recruitment, activation and proliferation of CD8+ memory T cells in an immunoprivileged site (1997) (35)
- Strong induction of 4-1BB, a growth and survival promoting costimulatory receptor, in HTLV-1-infected cultured and patients' T cells by the viral Tax oncoprotein. (2008) (35)
- Fertility of Nepalese Sherpas at moderate altitudes: comparison with high-altitude data. (1980) (35)
- Cytotoxic T lymphocyte lysis of HTLV-1 infected cells is limited by weak HBZ protein expression, but non-specifically enhanced on induction of Tax expression (2014) (34)
- Adult T cell leukemia/lymphoma: FoxP3(+) cells and the cell-mediated immune response to HTLV-1. (2011) (34)
- The role of cytotoxic T lymphocytes in human T-cell lymphotropic virus type 1 infection. (2000) (33)
- Defective interfering particles and virus evolution. (1993) (33)
- T-Cell Epitope Prediction: Rescaling Can Mask Biological Variation between MHC Molecules (2009) (32)
- Passively acquired antibodies to respiratory syncytial virus impair the secondary cytotoxic T-cell response in the neonatal mouse. (1986) (32)
- Recognition of respiratory syncytial virus fusion protein by mouse cytotoxic T cell clones and a human cytotoxic T cell line. (1989) (31)
- Ciclosporin A Proof of Concept Study in Patients with Active, Progressive HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (2012) (30)
- Kinetics of HTLV-1 reactivation from latency quantified by single-molecule RNA FISH and stochastic modelling (2019) (27)
- HTLV-1 infection: role of CTL efficiency (2008) (27)
- The impact of HTLV-1 on the cellular genome. (2017) (27)
- Analysis of substrate cleavage by recombinant protease of human T cell leukaemia virus type 1 reveals preferences and specificity of binding. (1994) (27)
- Histone H2A monoubiquitylation and p38-MAPKs regulate immediate-early gene-like reactivation of latent retrovirus HTLV-1. (2018) (26)
- HTLV-1 drives vigorous clonal expansion of infected CD8+ T cells in natural infection (2015) (26)
- Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective (2021) (25)
- Human T-cell leukaemia virus type I and neurological disease (1993) (24)
- Protection against lethal influenza virus encephalitis by intranasally primed CD8+ memory T cells. (1996) (24)
- HTLV-1 infection: what determines the risk of inflammatory disease? (2012) (24)
- Longer dinucleotide repeat polymorphism in matrix metalloproteinase-9 (MMP-9) gene promoter which correlates with higher HTLV-I Tax mediated transcriptional activity influences the risk of HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) (2004) (23)
- Do T cells cause HTLV‐1‐associated disease?: a taxing problem (1994) (23)
- Spastic paraparesis in a patient carrying defective human T cell leukemia virus type I (HTLV-I) provirus sequences but lacking a humoral or cytotoxic T cell response to HTLV-I. (1994) (22)
- Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-α. (2017) (22)
- Human immunodeficiency virus variants that escape cytotoxic T-cell recognition. (1992) (22)
- Retroviruses integrate into a shared, non-palindromic DNA motif (2016) (22)
- Effects of high altitude on endocrine function in the Sherpas of Nepal. (1978) (22)
- Regulation of Latency in the Human T Cell Leukemia Virus, HTLV-1. (2019) (21)
- Identification of host–pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank (2019) (21)
- Dynamics and mechanisms of clonal expansion of HIV-1-infected cells in a humanized mouse model (2017) (21)
- T Cell Receptor Vβ Staining Identifies the Malignant Clone in Adult T cell Leukemia and Reveals Killing of Leukemia Cells by Autologous CD8+ T cells (2016) (20)
- Early acquisition of cytolytic function and transcriptional changes in a primary CD8+ T-cell response in vivo. (2007) (20)
- Cell-mediated immune response to human T-lymphotropic virus type I. (2005) (20)
- Free serum haemoglobin is associated with brain atrophy in secondary progressive multiple sclerosis (2016) (20)
- Clonality of HTLV-2 in Natural Infection (2014) (19)
- In Vivo Selection of T-Cell Receptor Junctional Region Sequences by HLA-A2 Human T-Cell Lymphotropic Virus Type 1 Tax11-19 Peptide Complexes (2001) (19)
- Management of HAM/TSP (2020) (19)
- Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis (2011) (18)
- Phosphatidylinositol 3-kinase-δ (PI3K-δ) is a potential therapeutic target in adult T-cell leukemia-lymphoma (2018) (18)
- Is There a Role for HTLV-1-Specific CTL in Adult T-Cell Leukemia/Lymphoma? (2011) (17)
- Gene activation therapy: from the BLV model to HAM/TSP patients. (2009) (17)
- Interference with immune function by HTLV‐1 (2004) (17)
- Clonality of HTLV-2 in natural infection (2014) (17)
- What is required of an HIV vaccine? (1997) (17)
- Balancing the Robustness and Predictive Performance of Biomarkers (2013) (16)
- High frequencies of Th 1-type CD 4 T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1 – associated myelopathy / tropical spastic paraparesis (2002) (16)
- Integration Site and Clonal Expansion in Human Chronic Retroviral Infection and Gene Therapy (2014) (16)
- Risk stratification of adult T‐cell leukemia/lymphoma using immunophenotyping (2016) (16)
- Digoxin reveals a functional connection between HIV-1 integration preference and T-cell activation (2017) (16)
- Conference highlights of the 15th international conference on human retrovirology: HTLV and related retroviruses, 4-8 june 2011, Leuven, Gembloux, Belgium (2011) (15)
- Presentation of a new H-2D(k)-restricted epitope in the Tax protein of human T-lymphotropic virus type I is enhanced by the proteasome inhibitor lactacystin. (2002) (15)
- Protection against influenza virus encephalitis by adoptive lymphocyte transfer. (1997) (15)
- HTLV-1 Infection and Its Associated Diseases (2012) (15)
- Epigenetic changes around the pX region and spontaneous HTLV-1 transcription are CTCF-independent (2018) (14)
- Virus variation, escape from cytotoxic T lymphocytes and human retroviral persistence. (1998) (14)
- Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide. (2007) (14)
- Impact of Hepatitis B Virus Coinfection on Human T-Lymphotropic Virus Type 1 Clonality in an Indigenous Population of Central Australia (2018) (13)
- HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP (2014) (13)
- Reduced cell turnover in lymphocytic monkeys infected by human T-lymphotropic virus type 1 (2005) (13)
- Arsenic trioxide (As2O3) as a maintenance therapy for adult T cell leukemia/lymphoma (2020) (13)
- The relative contributions of infectious and mitotic spread to HTLV-1 persistence (2019) (12)
- Recent advances in the laboratory diagnosis of central nervous system infections (1996) (12)
- The MS-STAT trial: high dose simvastatin demonstrates neuroprotection without immune-modulation in secondary progressive multiple sclerosis (SPMS) - a phase II trial (2012) (12)
- Whole body clonality analysis in an aggressive STLV-1 associated leukemia (ATLL) reveals an unexpected clonal complexity. (2017) (11)
- Geographical distribution and disease associations of the CD45 exon 6 138G variant (2006) (10)
- Genetic polymorphisms in isolated Sherpa populations of Nepal. (1980) (9)
- Retrovirus infections of the nervous system. (1993) (9)
- Long-term clinical remission maintained after cessation of zidovudine and interferon-α therapy in chronic adult T-cell leukemia/lymphoma (2018) (9)
- Why the long latent period? (1990) (8)
- High-Throughput Mapping and Clonal Quantification of Retroviral Integration Sites. (2017) (8)
- Molecular remissions are observed in chronic adult T-cell leukemia/lymphoma in patients treated with mogamulizumab (2019) (8)
- Proceedings of the Frontiers of Retrovirology Conference 2016 (2016) (7)
- THE MS-STAT TRIAL: High Dose Simvastatin Slows Brain Atrophy and Delays Disability in Secondary Progressive Multiple Sclerosis: A Phase II Placebo-Controlled Trial (PL02.001) (2013) (7)
- infected peripheral blood mononuclear cells - virus type I but not interleukin-2 by human T-lymphotropic γ High production of interferon (2013) (7)
- The ethical dimensions of the biological sciences (1995) (6)
- Evolution in a chronic RNA virus infection: selection on HTLV-I tax protein differs between healthy carriers and patients with tropical spastic paraparesis (1996) (6)
- Genetic variability in the extracellular matrix protein as a determinant of risk for developing HTLV-I-associated neurological disease (2006) (6)
- Human T‐lymphotrophic virus type I and multiple sclerosis (1990) (6)
- HTLV-1 inserts an ectopic CTCF-binding site into the human genome (2015) (6)
- A new hypothesis for the pathogenesis of Human T-lymphotropic virus type 1 associated myelopathy/tropical spastic paraparesis (2009) (5)
- Meeting report on the 13th International Conference on Human Retrovirology: human T-cell leukemia virus research 30 years after adult T-cell leukemia. (2007) (5)
- Nosing ahead in the cold war (1990) (5)
- Selective clonal persistence of human retroviruses in vivo: radial chromatin organization, integration site and host transcription (2021) (5)
- Time-course of host cell transcription during the HTLV-1 transcriptional burst (2022) (5)
- Hematopoietic Stem Cell Infected with HTLV-1 Functions As a Viral Reservoir In Vivo (2016) (5)
- An interactive computer program for the analysis of HLA class II restriction fragment patterns. (1988) (4)
- Selective clonal persistence of human retroviruses in vivo: Radial chromatin organization, integration site, and host transcription (2022) (4)
- In vivo dynamics and adaptation of HTLV-1-infected clones under different clinical conditions. (2021) (4)
- Functional conservation of HTLV-1 rex balances the immune pressure for sequence variation in the rex gene. (1997) (4)
- The Polymerase Chain Reaction (1991) (4)
- Genetic control and dynamics of the cellular immune response to HTLV-I (1999) (4)
- Infective dermatitis associated with human T‐lymphotropic virus type 1 infection in Adelaide, South Australia (2018) (4)
- Viral Immunology from Math (2001) (4)
- HTLV-1 gene expression by individual infected clones determines susceptibility to lysis by cytotoxic T lymphocytes specific for Tax and HBZ (2014) (3)
- Estimation of clonal diversity in HTLV-1 infection (2014) (3)
- Haematological and molecular responses in patients with chronic ATLL treated with zidovudine and interferon-α (2014) (3)
- Roundtable: can experience with veterinary retroviral vaccines be applied to the human situation? (1996) (3)
- Ventilatory capacity in healthy Neplasese [proceedings]. (1977) (3)
- Molecular Basis of Virus Evolution: The influence of immunity on virus evolution (1995) (3)
- The potential of CD127 as a prognostic and residual disease marker in chronic adult T cell leukaemia/lymphoma (2014) (3)
- Cytotoxic T-Lymphocyte Activity Selects Immune Escape Variants during Primary HIV-1 Infection (1997) (3)
- Applied virology research (vol. 2): Virus variability, epidemiology and control (1991) (3)
- CD25+CCR4+ cells as a marker of HTLV-1-infected cells in peripheral blood (2014) (3)
- A proof of concept study of Infliximab for the treatment of HTLV-1-associated myelopathy (2014) (2)
- Spontaneous HTLV-1 transcription is accompanied by distinct epigenetic changes in the 5' and 3' long terminal repeats. (2018) (2)
- Microbial Subversion of Immunity Edited by Peter J. Lachmann and M. B. A. Oldstone Norwich, United Kingdom: Caister Academic Press, 2006 292 pp. $230 (cloth) (2007) (2)
- Integration site analysis in Japanese HTLV-1 infected asymptomatic carriers and HAM/TSP patients (2014) (2)
- Whole Exome Sequencing of Flow Purified Tumour Cells Reveals Recurrently Mutated Genes and Pathways in Adult T-Cell Lymphoma/Leukaemia (ATLL) (2015) (2)
- Recurrent TET2 mutations in adult T cell leukemia (2014) (2)
- The structure and genomic integration site of the HTLV-1 provirus determine selective clonal expansion and transformation to adult T cell leukaemia/lymphoma (2014) (2)
- Adult T-cell leukemia/lymphoma—pathobiology and implications for modern clinical management (2021) (2)
- Clonality of HTLV-1 differs between infected CD8+ T cells and infected CD4+ T cells in vivo (2014) (2)
- Host determinants of HTLV-1 integration site preference (2015) (2)
- Clinical, histological and immunological features of HTLV-1-associated infective dermatitis (2010) (2)
- Frequency and function of KIR+ CD8+ T cells in HTLV-1 infection (2014) (2)
- Response to HTLV-1 The Avidity and Lytic Efficiency of the CTL (2009) (1)
- HTLV-1-Tax and ICAM-1 act on T-cell signal pathways to polarize the MTOC at the virological synapse (2009) (1)
- Exclusion of actin microfilaments from the cell-cell contact zone in HTLV-1 infected T-lymphocyte during the establishment of a functional virological synapse (2011) (1)
- An interferon signature is associated with HAM/TSP but not viral containment in HTLV-1 infection (2011) (1)
- HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP (2014) (1)
- Author Correction: Dynamics and mechanisms of clonal expansion of HIV-1-infected cells in a humanized mouse model (2018) (1)
- Kinetics and intracellular compartmentalization of HTLV-1 gene expression (2011) (1)
- HTLV-1 clonality during chronic infection and BLV clonality during primary infection (2011) (1)
- AIDS: the evolving story. (2000) (1)
- Immune Response to Virus (2012) (1)
- First line treatment of acute and chronic ATLL with zidovudine (AZT) and interferon alpha (IFN-α): haematological and molecular responses (2011) (1)
- HIV infection. Why the long latent period? (1990) (1)
- Cytotoxic T cell responses to HTLV-1 infection (1992) (1)
- Clonality of HIV-1 and HTLV-1 infected cells in naturally coinfected individuals. (2021) (1)
- Cell-to-cell contact with HTLV-1-infected T cell reduces dendritic cell immune functions and contributes to infection in trans. (2017) (1)
- Raw data for SELDI-TOF low range from article: Free serum haemoglobin is associated with brain atrophy in secondary progressive multiple sclerosis (2016) (1)
- Raw data for RBC, Hb and haematocrit from article: Free serum haemoglobin is associated with brain atrophy in secondary progressive multiple sclerosis (2016) (1)
- Adult T-cell leukemia: genomic analysis. (2022) (1)
- HTLV-1 Raw Image Data (2017) (1)
- Clonality, latency and integration of HTLV-1 in vivo (2013) (1)
- Clonality, latency and integration of HTLV-1 in vivo (2013) (1)
- A proof of concept study of Infliximab for the treatment of HTLV-1-associated myelopathy (2014) (0)
- The bridge study - A double-blind placebo controlled trial of zidovudine plus lamivudine for treatment of patients with HTLV-I-associated myelopathy. (2003) (0)
- Haematological and molecular responses in patients with chronic ATLL treated with zidovudine and interferon-α (2014) (0)
- Virology. Nosing ahead in the cold war. (1990) (0)
- CD8 malignant proliferation in association with human T cell lymphotropic Virus 1 infection: a case report (2015) (0)
- Immunogenetics of HTLV-I infection (1999) (0)
- Ethics and Biotechnology (1996) (0)
- Bayer Award Presentations (2006) (0)
- Phosphatidylinositol 3-kinase-δ (PI3K-δ) is a potential therapeutic target in adult T-cell leukemia-lymphoma (2018) (0)
- Why reproduction is difficult at high altitude (2015) (0)
- HTLV-1 gene expression by individual infected clones determines susceptibility to lysis by cytotoxic T lymphocytes specific for Tax and HBZ (2014) (0)
- HLA-A*02 PROTECTS AGAINST HAM/TSP BY REDUCING HTLV-I PROVIRUS LOAD. (1999) (0)
- Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients (2016) (0)
- Susceptibility of HBZ and Tax expressing primary HTLV-1+ T cell clones to CTL lysis (2011) (0)
- Treatment of an aggressive STLV-1 associated lymphoma in a naturally infected baboon (2015) (0)
- Estimation of clonal diversity in HTLV-1 infection (2014) (0)
- Killer Cell Immunoglobulin-Like Receptor Genotype and HTLV-1 Associated Disease’s Susceptibilities. (2005) (0)
- Positive selection mediated by cytotoxic T lymphocytes influences HIV-1 evolution during primary infection (1997) (0)
- Clonality of HTLV-1 differs between infected CD8+ T cells and infected CD4+ T cells in vivo (2014) (0)
- Cytotoxic T-cell abundance and virus load in human immunode ciency virus type 1 and human T-cell leukaemia virus type 1 (2001) (0)
- Human T-lymphotropic virus type 1(HTLV-1) integration, HTLV-1-associated infective dermatitis (IDH) and the risk of Adult T cell leukaemia/lymphoma (ATLL) (2011) (0)
- Recurrent TET2 mutations in adult T cell leukemia (2014) (0)
- Comparative analysis of gene expression patterns in the HTLV-1 infected T-cell clones (2015) (0)
- Tumor suppressor in lung cancer identifies latency infected cells in non malignant HTLV-1 infection (2015) (0)
- HDAC inhibitors Panobinostat and Romidepsin enhance tax transcription in HTLV-1-infected cell lines and freshly isolated patients’ T-cells (2022) (0)
- G-103 Regulation of HTLV-1 proviral latency (2018) (0)
- Host determinants of HTLV-1 integration site preference (2015) (0)
- A frequent PLCγ1 mutation in adult T-cell leukemia/lymphoma determines functional properties of the malignant cells. (2022) (0)
- How the genomic environment of the HTLV-1 provirus impacts on clone fitness (2010) (0)
- Persistent risk of adult T-cell leukemia/lymphoma after neonatal HTLV-1 infection through exchange transfusion (2017) (0)
- Tumor suppressor in lung cancer identifies latency infected cells in non malignant HTLV-1 infection (2015) (0)
- Short title: Early cytolytic & transcriptional activity in CTLs (2016) (0)
- Defective interfering particles and • evolution virus (1993) (0)
- GENETIC EPIDEMIOLOGY STUDY OF HTLV-1 IN SOUTHERN JAPAN:USE OF A CANDIDATE GENE APPROACH (1999) (0)
- T-cell receptor chain Vbeta subunit staining to quantify the malignant clone in adult T-cell leukemia (2015) (0)
- The functional consequences of sequence variation of rex in HTLV-1-infected patients (2007) (0)
- HTLV-1 Proviral Load after Two Months' Treatment with Anti-CCR4 Monoclonal Antibody Mogamulizumab Predicts a Molecular Response to Disease and Durable Clinical Remission in Leukaemic Subtypes of Adult T-Cell Leukaemia/Lymphoma (2016) (0)
- Three plasma biomarkers of HTLV-1-associated myelopathy/tropical spastic paraparesis (2011) (0)
- Practical Molecular Virology (1993) (0)
- CD25+CCR4+ cells as a marker of HTLV-1-infected cells in peripheral blood (2014) (0)
- CYTOTOXIC T-CELL FREQUENCY AND LYMPHOCYTE ACTIVATION PHENOTYPE ARE CORRELATED WITH HTLV-I PROVIRAL LOAD (1999) (0)
- Integration site analysis in Japanese HTLV-1 infected asymptomatic carriers and HAM/TSP patients (2014) (0)
- Abstract 2715: Host genomic environment determines HTLV-1 clone sizein vivo (2011) (0)
- The potential of CD127 as a prognostic and residual disease marker in chronic adult T cell leukaemia/lymphoma (2014) (0)
- Proceedings of the Frontiers of Retrovirology Conference 2016 (2016) (0)
- Dynamics and mechanisms of clonal expansion of HIV-1-infected cells in a humanized mouse model (2017) (0)
- Identification of long-range chromatin interactions between HTLV-1 and the host genome (2015) (0)
- The potential of CD127 as a prognostic and residual disease marker in chronic adult T cell leukaemia/lymphoma (2014) (0)
- Variants of human T-cell leukaemia virus type 1 (HTLV-1) Tax protein ACT as antagonists in the recognition of peptide epitopes by cytotoxic T-cells in infected patients (2007) (0)
- Treatment of an aggressive STLV-1 associated lymphoma in a naturally infected baboon (2015) (0)
- REVERSIBLE MEMBRANE DAMAGE OF B CELL IN HAM/TSP (1999) (0)
- Identification of long-range chromatin interactions between HTLV-1 and the host genome (2015) (0)
- Neurotropic Viral Infections: Human T-lymphotropic virus type 1 and disease in the central nervous system (2008) (0)
- Abstract SY23-03: How does HTLV-1 cause leukemia (2017) (0)
- Estimating rates of de novo infection and mitotic replication in HTLV-1 persistence: de novo infection continues after early infection (2015) (0)
- Molecular characterization of heterogeneity in adult T-cell leukaemia/lymphoma (2015) (0)
- A-101 The human leukemia virus-HTLV-1—persistence and pathogenesis (2019) (0)
- Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences: 355 (1400) (2000) (0)
- Report on the 13 th International Conference on Human Retrovirology : Human T-Cell Leukemia Virus Research 30 Years after Adult T-Cell Leukemia (2007) (0)
- The MS-STAT Trial: A Phase II Trial of High Dose Simvastatin for Secondary Progressive Multiple Sclerosis (SPMS): Initial Results (2012) (0)
- PLOS Pathogens 2017 Reviewer and Editorial Board Thank You (2018) (0)
- Immunogenetics of the Host Response to Viral Infections (2002) (0)
- HLA-DRB1*0101 POSITIVITY IN HTLV-I INFECTED INDIVIDUALS MAY ACCELERATE DEVELOPMENT OF HAM/TSP (1999) (0)
- High production of interferong but not interleukin-2 by human T-lymphotropic virus type I–infected peripheral blood mononuclear cells (2001) (0)
- Cytotoxic T lymphocyte lysis of HTLV-1 infected cells is limited by weak HBZ protein expression, but non-specifically enhanced on induction of Tax expression (2014) (0)
- Author Correction: Dynamics and mechanisms of clonal expansion of HIV-1-infected cells in a humanized mouse model (2018) (0)
- The transcriptome of HTLV-1-infected primary cells following reactivation reveals changes to host gene expression central to the proviral life cycle (2023) (0)
- The structure and genomic integration site of the HTLV-1 provirus determine selective clonal expansion and transformation to adult T cell leukaemia/lymphoma (2014) (0)
- Virus strategies: Molecular biology and pathogenesis: edited by Walter Doerfler and Petra Böhm VCH, 1993. DM268.00/£109.00 hbk (xxiii + 542 pages) ISBN 3 527 30027 9 (1994) (0)
- A capsid-dependent integration program linking T cell activation to HIV-1 gene expression (2016) (0)
- Comparative analysis of gene expression patterns in the HTLV-1 infected T-cell clones (2015) (0)
- Molecular characterization of heterogeneity in adult T-cell leukaemia/lymphoma (2015) (0)
- Proteinase of human T-cell leukaemia virus type 1 shows preferences of substrate cleavage (2007) (0)
- Preferential Infection with HTLV-I Immunodominance Hierarchy and T Cells: + (HTLV-I)-Specific CD4 Human T Cell Lymphotropic Virus Type I (2004) (0)
- Transgenic models of human viral and immunological disease: Current topics in microbiology and immunology, Vol. 206: Edited by F.V. Chisari and M.B.A. Oldstone. Springer Verlar, Berlin. ISBN 3-540-59341-1. Price: DM 198 (1996) (0)
- Retroviruses integrate into a shared, non-palindromic motif (2015) (0)
- PROCESSING AND PRESENTATION OF HTLV-I TAX AND REX PROTEINS (1999) (0)
- 280 Cell-to-cell contact with HTLV-1-infected T cells reduces dendritic cell immune functions and contributes to infection in trans (2016) (0)
- T-cell receptor chain Vbeta subunit staining to quantify the malignant clone in adult T-cell leukemia (2015) (0)
- Smaller baseline brain volume and higher atrophy rate over two years is associated with poorer clinical outcomes: post hoc analysis of the MS-STAT trial in Secondary Progressive MS (P7.259) (2015) (0)
- HTLV-1 drives vigorous clonal expansion of infected CD8+ T cells in natural infection (2015) (0)
- Molecular characterization of heterogeneity in adult T-cell leukaemia/lymphoma (2015) (0)
- A GENETIC EPIDEMIOLOGICAL STUDY OF HTLV-I INFCTION IN SOUTHERN JAPAN: A CANDIDATE GENE APPROACH. (1999) (0)
- The MS-STAT trial: a randomised placebo-controlled phase II trial of high dose simvastatin in secondary progressive multiple sclerosis (SPMS) (2012) (0)
- Frequency and function of KIR+ CD8+ T cells in HTLV-1 infection (2014) (0)
- Naturally occuring mutations of HTLV-1 proviral genome within HAM/TSP patients and asymptomatic carriers; the influence of proviral load, host genotype and disease state. (1999) (0)
- The potential of CD127 as a prognostic and residual disease marker in chronic adult T cell leukaemia/lymphoma (2014) (0)
- Viral Immunology from Math<product> <article-title>Virus Dynamics: Mathematical Principles of Immunology and Virology</article-title> <contrib-group><contrib> <name index="Nowak, Martin A."> <given-names>Martin A.</given-names> <surname>Nowak</surname> </name> </contrib></contrib-group> <contrib-gro (2009) (0)
- Molecular characterization of heterogeneity in adult T-cell leukaemia/lymphoma (2015) (0)
- Modified Ashworth Scale testing muscle spasticity (0–72 weeks). (2012) (0)
- The Pathogenesis of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (2016) (0)
- T-cells select defective variants of HTLV-I (2007) (0)
- HTLV-1 persistence and the oncogenesis of adult T cell leukemia/lymphoma. (2023) (0)
- Estimating rates of de novo infection and mitotic replication in HTLV-1 persistence: de novo infection continues after early infection (2015) (0)
- Dynamics and consequences of the HTLV-1 proviral plus-strand burst (2022) (0)
- CD8 malignant proliferation in association with human T cell lymphotropic Virus 1 infection: a case report (2015) (0)
- AGGRECAN GENETIC POLYMORPHISM AND ITS RELATION TO THE PATHOGENESIS OF HAM (1999) (0)
This paper list is powered by the following services:
Other Resources About Charles Bangham
What Schools Are Affiliated With Charles Bangham?
Charles Bangham is affiliated with the following schools:
